원숭이두창(EMPOX) 진단 시장 : 어세이별, 국가별, 제품별, 장소별-경영진 및 컨설턴트 가이드, 시장 분석 및 예측(2024-2028년)

OVERVIEW:

Monkeypox is being declared a health emergency. Governments around the world are preparing to use widespread testing to get in front of this threat from the beginning. Opportunities abound for the In Vitro Diagnostic Industry.

The report forecasts the market size out to 2028. Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnostics and the Genomics Revolution are merging to create new diagnostic opportunities.

All report data is available in Excel format on request.

Table of Contents

1. Market Guides

• 1.1. Situation Analysis
• 1.2. Guide for Executives and Marketing Staff
• 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

• 2.1. An Overview of Monkeypox Diagnostics
  • 2.1.1. The 2022 Outbreak
• 2.2. Market Definition
  • 2.2.1. Market Size
  • 2.2.2. Currency
  • 2.2.3. Years
  • 2.2.4. PCR
  • 2.2.5. NGS
  • 2.2.6. Immunoassay
  • 2.2.7. Rapid Diagnostics
  • 2.2.8. Limitations
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics

3. Monkeypox - Current Science

• 3.1. What is Monkeypox?
• 3.2. Outbreaks
• 3.3. Transmission
• 3.4. Signs and symptoms
• 3.5. Diagnosis
• 3.6. Therapeutics
  • 3.6.1. Vaccination
  • 3.6.2. Prevention
    • 3.6.2.1. Reducing the risk of human-to-human transmission
    • 3.6.2.2. Reducing the risk of zoonotic transmission
• 3.7. How monkeypox relates to smallpox

4. Industry Overview

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Diagnostic Test Developer
  • 4.1.3. Pharmaceutical/Reagent Supplier
  • 4.1.4. Independent Testing Lab
  • 4.1.5. Public National/regional lab
  • 4.1.6. Hospital lab
  • 4.1.7. Physician Lab
  • 4.1.8. Audit Body
  • 4.1.9. Certification Body

5. Market Trends

• 5.1. Factors Driving Growth
  • 5.1.1. Prevalence
  • 5.1.2. Surveillance
  • 5.1.3. Pandemic Wind Down
  • 5.1.4. Viral Zeitqeist
  • 5.1.5. Healthcare Spend
• 5.2. Factors Limiting Growth
  • 5.2.1. The Cost Curve Shrinks the Market
  • 5.2.2. Transmission Outlook
  • 5.2.3. Adoption Lag and Cost Control
• 5.3. Diagnostic Technology Development
  • 5.3.1. The Multiplex Opportunity
  • 5.3.2. Shifting Role of Physicians in Diagnosis
  • 5.3.3. Diagnostics Moves Out of the Lab
  • 5.3.4. Biomarkers and Algorithms
  • 5.3.5. Rapid Testing Changing Medical Practice
  • 5.3.6. Genome Role and Big Data

6. Mpox Diagnostics - Recent Developments

• 6.1. Recent Developments - Importance and How to Use This Section
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. WHO Declares MPOX a Health Emergency
• 6.3. Human monkeypox disease prediction
• 6.4. Most Dangerous Monkeypox Virus Yet
• 6.5. South Africa reports second mpox death
• 6.6. New Strain of MPOX Raising Alarm
• 6.7. Labcorp Receives EUA for Home Mpox Test
• 6.8. Ultrasensitive single-step CRISPR detection of MPOX virus
• 6.9. Many new mpox cases are in China
• 6.10. U.S. to declare monkeypox a public health emergency
• 6.11. BioGX Gets CE-IVD Mark for Multigene POC Test
• 6.12. World Health Organization declares monkeypox a global emergency
• 6.13. Quest Begins Offering Internally Developed Monkeypox Test
• 6.14. CDC, Abbott, Roche, BioMerieux Get FDA 510(k) Clearances
• 6.15. Commercial, Academic Labs Ramp Up Monkeypox Testing
• 6.16. Becton Dickinson, CerTest Biotec Collaborate on Monkeypox MDx
• 6.17. Monkeypox Virus Sequenced

7. Profiles of Key Companies

• 7.1. Abbott Laboratories
• 7.2. Aegis Science Corporation
• 7.3. Applied DNA Sciences
• 7.4. Beckman Coulter Diagnostics (Danaher)
• 7.5. Becton, Dickinson and Company
• 7.6. BGI Genomics Co. Ltd
• 7.7. BioFire Diagnostics (bioMerieux)
• 7.8. BioGX
• 7.9. bioMerieux Diagnostics
• 7.10. Bio-Rad Laboratories, Inc.
• 7.11. Cepheid (Danaher)
• 7.12. Cerstest Biotec
• 7.13. Flow Health
• 7.14. Laboratory Corporation of America
• 7.15. Mayo Clinic Laboratories
• 7.16. Novacyt
• 7.17. Proof Diagnostics
• 7.18. Qiagen
• 7.19. Quest Diagnostics
• 7.20. Roche Diagnostics
• 7.21. Siemens Healthineers
• 7.22. Sonic Healthcare
• 7.23. Sysmex
• 7.24. Thermo Fisher Scientific
• 7.25. Vela Diagnostics

8. Monkeypox Global Diagnostic Markets Overview

• 8.1. Monkeypox Diagnostics - Global Market Overview by Country
  • 8.1.1. Table - Global Market by Country
  • 8.1.2. Chart - Global Market by Country
• 8.2. Global Monkeypox Diagnostics Markets Overview by Assay
  • 8.2.1. Table - Global Market by Assay
  • 8.2.2. Chart - Global Market by Assay - Segments Growth
  • 8.2.3. Chart - Global Market by Assay - Share by Year
  • 8.2.4. Chart - Global Market by Assay
  • 8.2.5. Chart - Global Market by Assay - Base Year
  • 8.2.6. Chart - Global Market by Assay - Final Year
• 8.3. Global Monkeypox Diagnostics Markets Overview by Product
  • 8.3.1. Table - Global Market by Product
  • 8.3.2. Chart - Global Market by Product - Segments Growth
  • 8.3.3. Chart - Global Market by Product - Share by Year
  • 8.3.4. Chart - Global Market by Product
  • 8.3.5. Chart - Global Market by Product - Base Year
  • 8.3.6. Chart - Global Market by Product - Final Year
• 8.4. Global Monkeypox Diagnostics Markets Overview by Place
  • 8.4.1. Table - Global Market by Place
  • 8.4.2. Chart - Global Market by Place - Segments Growth
  • 8.4.3. Chart - Global Market by Place - Share by Year
  • 8.4.4. Chart - Global Market by Place
  • 8.4.5. Chart - Global Market by Place - Base Year
  • 8.4.6. Chart - Global Market by Place - Final Year

9. Monkeypox Diagnostic Market - by Assay

• 9.1. Monkeypox Diagnostic - PCR
  • 9.1.1. Table Monkeypox Diagnostic PCR - by Country
  • 9.1.2. Chart - Monkeypox Diagnostic PCR Growth
• 9.2. Monkeypox Diagnostic - NGS
  • 9.2.1. Table Monkeypox Diagnostic NGS - by Country
  • 9.2.2. Chart - Monkeypox Diagnostic - NGS Growth
• 9.3. Monkeypox Diagnostic - Immunoassay
  • 9.3.1. Table Monkeypox Immunoassay - by Country
  • 9.3.2. Chart - Monkeypox Diagnostic - Immunoassay Growth
• 9.4. Monkeypox Diagnostic - Other Assay
  • 9.4.1. Table Monkeypox Diagnostic Other Assay - by Country
  • 9.4.2. Chart - Monkeypox Diagnostic - Other Assay Growth

10. Global Monkeypox Diagnostics Markets - By Product

• 10.1. Monkeypox Diagnostic - Instrumentation
  • 10.1.1. Table Monkeypox Diagnostic Instrumentation - by Country
  • 10.1.2. Chart - Monkeypox Diagnostic Instrumentation Growth
• 10.2. Monkeypox Diagnostic - Consumables
  • 10.2.1. Table Monkeypox Diagnostic Consumables - by Country
  • 10.2.2. Chart - Monkeypox Diagnostic Consumables
• 10.3. Monkeypox Diagnostic - Software & Service
  • 10.3.1. Table Monkeypox Diagnostic Software & Service - by Country
  • 10.3.2. Chart - Monkeypox Diagnostic - Software & Service Growth

11. Global Monkeypox Diagnostics Markets - By Place

• 11.1. Monkeypox Diagnostic - Hospital
  • 11.1.1. Table Monkeypox Diagnostic Hospital - by Country
  • 11.1.2. Chart - Monkeypox Diagnostic Hospital Growth
• 11.2. Monkeypox Diagnostic - Clinic/POL
  • 11.2.1. Table Monkeypox Diagnostic Clinic/POL - by Country
  • 11.2.2. Chart - Monkeypox Diagnostic Clinic/POL Growth
• 11.3. Monkeypox Diagnostic - Other Place
  • 11.3.1. Table Monkeypox Diagnostic Other Place - by Country
  • 11.3.2. Chart - Monkeypox Diagnostic Other Place

12. Appendices

• 12.1. Commercially Available Monkeypox Tests
• 12.2. United States Medicare System: Clinical Laboratory Fees Schedule